As a novel checkpoint inhibitor, TTI-621 (SIRPα-IgG1 Fc) is a soluble, fully human recombinant fusion protein designed to block the CD47 “do not eat me” signal by IFN primed macrophages that triggers tumor cell phagocytosis. This evidence concerns the gene CD47 and neoplasm.